Literature DB >> 9523550

Splicing of a regulated exon reveals additional complexity in the axonal microtubule-associated protein tau.

M L Wei1, A Andreadis.   

Abstract

Tau is a microtubule-associated protein whose transcript undergoes complex regulated splicing in the mammalian nervous system. Exon 6 of the gene is an alternatively spliced cassette whose expression pattern and splicing regulation had not been previously analyzed in the human. The expression profile of exon 6 is completely different from that of the better-analyzed exons 2, 3, 4A, and 10, implying the utilization of distinct regulatory factors. The default splicing behavior of the exon had demonstrated the existence of what were initially considered cryptic splice sites. However, analysis of the expression pattern of exon 6 suggests that these splice sites are utilized in certain human tissues and, if translated, would result in a radically altered tau protein. Lastly, expression of exon 6 minigene constructs in cells indicates that its flanking exons are involved in its inclusion and in the modulation of the ratio of its variants.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9523550     DOI: 10.1046/j.1471-4159.1998.70041346.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  12 in total

1.  PSF suppresses tau exon 10 inclusion by interacting with a stem-loop structure downstream of exon 10.

Authors:  Payal Ray; Amar Kar; Kazuo Fushimi; Necat Havlioglu; Xiaoping Chen; Jane Y Wu
Journal:  J Mol Neurosci       Date:  2011-09-01       Impact factor: 3.444

2.  RNA helicase p68 (DDX5) regulates tau exon 10 splicing by modulating a stem-loop structure at the 5' splice site.

Authors:  Amar Kar; Kazuo Fushimi; Xiaohong Zhou; Payal Ray; Chen Shi; Xiaoping Chen; Zhiren Liu; She Chen; Jane Y Wu
Journal:  Mol Cell Biol       Date:  2011-02-22       Impact factor: 4.272

Review 3.  The role of tau kinases in Alzheimer's disease.

Authors:  Philip J Dolan; Gail V W Johnson
Journal:  Curr Opin Drug Discov Devel       Date:  2010-09

Review 4.  The many faces of tau.

Authors:  Meaghan Morris; Sumihiro Maeda; Keith Vossel; Lennart Mucke
Journal:  Neuron       Date:  2011-05-12       Impact factor: 17.173

5.  Expression and silencing of the microtubule-associated protein Tau in breast cancer cells.

Authors:  Tatiana Spicakova; Maureen M O'Brien; George E Duran; Alejandro Sweet-Cordero; Branimir I Sikic
Journal:  Mol Cancer Ther       Date:  2010-11-09       Impact factor: 6.261

6.  Microtubule-associated protein tau in human prostate cancer cells: isoforms, phosphorylation, and interactions.

Authors:  Skye Souter; Gloria Lee
Journal:  J Cell Biochem       Date:  2009-10-15       Impact factor: 4.429

7.  Tau 6D and 6P isoforms inhibit polymerization of full-length tau in vitro.

Authors:  Nichole E Lapointe; Peleg M Horowitz; Angela L Guillozet-Bongaarts; Andres Silva; Athena Andreadis; Lester I Binder
Journal:  Biochemistry       Date:  2009-12-29       Impact factor: 3.162

8.  Assigning backbone NMR resonances for full length tau isoforms: efficient compromise between manual assignments and reduced dimensionality.

Authors:  Nicholas W Harbison; Shibani Bhattacharya; David Eliezer
Journal:  PLoS One       Date:  2012-04-18       Impact factor: 3.240

Review 9.  Regulation of human MAPT gene expression.

Authors:  Marie-Laure Caillet-Boudin; Luc Buée; Nicolas Sergeant; Bruno Lefebvre
Journal:  Mol Neurodegener       Date:  2015-07-14       Impact factor: 14.195

Review 10.  Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy.

Authors:  Marie-Laure Caillet-Boudin; Francisco-Jose Fernandez-Gomez; Hélène Tran; Claire-Marie Dhaenens; Luc Buee; Nicolas Sergeant
Journal:  Front Mol Neurosci       Date:  2014-01-09       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.